"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...

Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...

The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

The exposure has been great for her contact list — so good ... his deep-seated disapproval of her decision to take a weight-loss drug — “that what I’ve done is the easy button,” Jeanne ...

Pharmacists must verify a person’s body mass index (BMI) via a video consultation, in person, or through accessing GP or ...

insurers often don't pay for these drugs for weight loss. List prices exceed $1,000 per month and spotty insurance coverage means many consumers struggle to afford the medications, researchers said.

One study compared GLP-1RAs against another weight loss drug, bupropion-naltrexone ... As these drugs continue to gain popularity and achieve commercial success, their list of indications may also ...

Danish drugmaker Novo Nordisk reported fourth quarter and full year 2024 earnings Wednesday, beating Wall Street's ...

Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which ...